non-EEA authorised comparator in clinical studies

• Business
• European Union
• Management
• Pharma & Biotech

European Medicines Agency publishes its revised overarching guideline on biosimilars; possibility for medicines developers to use non-EEA authorised comparator in clinical studies

EMA to allow use of non-EEA authorised comparator in clinical studies; new guidance applicable as of today LONDON, 30-10-2014 —…